SWISS REJU wins prestigious COSMOPOLITAN “Best of the Best” beauty award, taking innovative slimming and body contouring to the next level

HONG KONG, Dec. 14, 2022 /PRNewswire/ — SWISS REJU, a high-end beauty brand located at the heart of Central Hong Kong, is thrilled to announce it has been honored with the  “COSMOPOLITAN Best of the Best Panel’s Choice Award”, a much coveted prize for beauty brands.

Each year, thousands of new beauty products and services are launched into the market. Seasoned beauty editors and aesthetic experts weigh in on different products to discover true game changers. This year, international media giant COSMOPOLITAN awarded SWISS REJU in their Panel’s Choice category, recognising the outstanding effects of its signature body contouring program SWISS REJU K-Lipolysis.


SWISS REJU wins prestigious COSMOPOLITAN Best of the Best Panel’s Choice Award

The COSMOPOLITAN “Best of the Best Panel’s Choice Award” is the most prestigious and recognized in the world of luxury beauty, and selects the most outstanding products and services in each category including skincare, cosmetics and beauty services. In order to be shortlisted, innovativeness, originality and marketing impact are all important factors to be considered by the selection panel. Winning this award is expected to place SWISS REJU as a rising star within the world of high end beauty and slimming services. “We are truly honored to have won such a prestigious award! We thank the beauty editors and panel at COSMOPOLITAN for this wonderful recognition”, says SWISS REJU.

SWISS REJU introduces the most powerful and effective body contouring technology from all over the world, with many of its slimming machines already obtained US FDA, European CE or Korean KFDA certifications, the rigorous safety and effectiveness verifications required by regulatory authorities.

Learn more about SWISS REJU: http://www.reju.hk

Subscribe on LinkedIn

Get the free newsletter

Subscribe to MedicaEx for top news, trends & analysis

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

PR Newswire is solely responsible for the content of the above news submissions. If there are any violations of laws, violations of the membership terms of this website, or the risk of infringing on the rights of third parties, PR Newswire will be solely responsible for legal and damage compensation. Responsibility has nothing to do with MedicaEx.

Are you in?

Subscribe to receive exclusive content and notifications to your inbox

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.